Latest On Principia Biopharma Inc (PRNB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-10-05 13:45 EST | Analyst Rating | The Analyst Target Price has decreased from $93 to $86. | Sell |  |
| 2020-10-01 09:50 EST | Analyst Rating | The Analyst Target Price has decreased from $98.75 to $93. | Sell | |
| 2020-09-30 09:52 EST | Analyst Rating | The Analyst Target Price has decreased from $99 to $98.75. | Sell | |
| 2020-09-29 05:26 EST | Analyst Rating | The Analyst Target Price has decreased from $99.38 to $99. | Sell | |
| 2020-09-26 13:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-22 20:42 EST | Insider Trade | Roy C. Hardiman has directly disposed of 5,000 shares and currently holds 117,761 shares. | Sell | |
| 2020-09-22 20:42 EST | Insider Trade | Roy C. Hardiman has directly acquired 2,242 shares and currently holds 122,761 shares. | Buy | |
| 2020-09-22 20:42 EST | Insider Trade | Roy C. Hardiman has directly acquired 2,758 shares and currently holds 120,519 shares. | Buy | |
| 2020-09-18 14:56 EST | News | Dosing underway for Principia's rilzabrutinib mid-stage study in IgG4-related disease | N/A | |
| 2020-09-17 05:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 03:57 EST | News | Sanofi to acquire Principia Biopharma | N/A | |
| 2020-09-01 05:26 EST | Analyst Rating | The Analyst Target Price has decreased from $99.88 to $99.38. | Sell | |
| 2020-08-27 05:23 EST | Analyst Rating | The Analyst Target Price has decreased from $100.38 to $99.88. | Sell | |
| 2020-08-20 20:41 EST | Insider Trade | Dolca Thomas has directly disposed of 15,000 shares and currently holds 1,826 shares. | Sell | |
| 2020-08-20 20:41 EST | Insider Trade | Dolca Thomas has directly acquired 15,000 shares and currently holds 16,826 shares. | Buy | |
| 2020-08-20 20:11 EST | Insider Trade | CHRISTOPHER Y CHAI has directly disposed of 7,500 shares and currently holds 3,539 shares. | Sell | |
| 2020-08-20 20:11 EST | Insider Trade | CHRISTOPHER Y CHAI has directly acquired 7,500 shares and currently holds 11,039 shares. | Buy | |
| 2020-08-19 21:34 EST | News | Principia Bought By Sanofi, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-08-19 05:31 EST | Analyst Rating | The Analyst Target Price has decreased from $101.88 to $100.38. | Neutral | |
| 2020-08-18 05:30 EST | Analyst Rating | The Analyst Target Price has increased from $100.67 to $101.88. | Buy | |
| 2020-08-14 09:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 100 shares and currently holds 31,739 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 1,108 shares and currently holds 31,839 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 700 shares and currently holds 32,947 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 2,534 shares and currently holds 33,647 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 700 shares and currently holds 36,181 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly disposed of 858 shares and currently holds 36,881 shares. | Sell | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly acquired 3,553 shares and currently holds 37,739 shares. | Buy | |
| 2020-08-12 20:26 EST | Insider Trade | David M Goldstein has directly acquired 2,447 shares and currently holds 34,186 shares. | Buy | |
| 2020-08-12 05:38 EST | Analyst Rating | The Analyst Target Price has increased from $97.11 to $100.67. | Buy | |
| 2020-08-10 05:39 EST | Analyst Rating | The Analyst Target Price has increased from $86.67 to $97.11. | Buy | |
| 2020-08-07 09:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 00:40 EST | News | Principia Biopharma EPS beats by $1.36, beats on revenue | N/A | |
| 2020-08-06 21:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 13:28 EST | Analyst Rating | The Analyst Target Price has increased from $81.25 to $86.67. | Buy | |
| 2020-07-30 05:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 18:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-18 00:58 EST | News | Principia Sanofi Rumors, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-07-17 20:33 EST | Insider Trade | Dolca Thomas has directly disposed of 15,000 shares and currently holds 1,826 shares. | Sell | |
| 2020-07-17 20:33 EST | Insider Trade | Dolca Thomas has directly acquired 15,000 shares and currently holds 16,826 shares. | Buy | |
| 2020-07-16 23:30 EST | News | Principia Biopharma up 12% on rumored Sanofi interest | N/A | |
| 2020-07-09 09:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-08 01:29 EST | Analyst Rating | The Analyst Target Price has increased from $78.57 to $81.25. | Buy | |
| 2020-07-02 20:58 EST | Insider Trade | Alan Colowick has directly disposed of 7,500 shares and currently holds 0 shares. | Sell | |
| 2020-07-02 20:58 EST | Insider Trade | Alan Colowick has directly acquired 7,500 shares and currently holds 7,500 shares. | Buy | |
| 2020-07-01 17:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 20:41 EST | Insider Trade | Martin Babler has directly disposed of 2,502 shares and currently holds 810 shares. | Sell | |
About Principia Biopharma Inc (PRNB):
Principia Biopharma Inc., a late-stage biopharmaceutical company, focuses on developing novel therapies for immune-mediated diseases. The company is developing rilzabrutinib, an inhibitor that is in Phase III clinical trials for the treatment of pemphigus, a chronic skin disease, as well as and pemphigus foliaceus; in a Phase 1/2 trial for the treatment of immune thrombocytopenia; and a Phase 2 trial for the treatment of IgG4-related disease. It is also developing PRN2246/SAR442168, an inhibitor, which is in Phase Ii clinical trial for treating multiple sclerosis (MS) and other central nervous system (CNS) diseases; and PRN473, a drug candidate that is in Phase I clinical trial for the treatment of immune-medicated diseases. The company has a collaboration agreement with Genzyme Corporation to develop relapsing and progressive MS and other diseases of the CNS. Principia Biopharma Inc. was incorporated in 2008 and is headquartered in South San Francisco, California. As of September 25, 2020, Principia Biopharma Inc. operates as a subsidiary of Sanofi.
General
- Name Principia Biopharma Inc
- Symbol PRNB
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 124
- Fiscal Year EndDecember
- IPO Date2018-09-14
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.principiabio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 60.73
- Price/Book (Most Recent Quarter) 9.46
- Enterprise Value Revenue 60.47
View More
Financials
- Most Recent Quarter 2020-06-30
- Current Year EPS Estimate -$3.65
- Next Year EPS Estimate -$5.22
- Profit Margin -138%
- Operating Margin -148%
- Return on Assets -16%
- Return on Equity -26%
- Revenue 50 million
- Earnings Per Share -$0.09
- Revenue Per Share $1.65
- Gross Profit 35.16 million
- Quarterly Earnings Growth 66.7%
View More
Highlights
- Market Capitalization 3.33 billion
- EBITDA 6.9 million
- Analyst Target Price $86
- Book Value Per Share $10.60
View More
Share Statistics
- Shares Outstanding 33.24 million
- Shares Float 26.62 million
- % Held by Insiders 139%
- % Held by Institutions 100.78%
- Shares Short 1.58 million
- Shares Short Prior Month 2 million
- Short Ratio 0.5
- Short % of Float 6%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 0.86
- 52 Week High $101.89
- 52 Week Low $28.86
- 50 Day Moving Average 100.12
- 200 Day Moving Average 75.08
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
Principia Biopharma Inc (PRNB) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Principia Biopharma Inc (PRNB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-08-06 | $N/A | $0.31 | -$0.80 | 138.75% |
| 2020-03-31 | 2020-05-06 | $N/A | -$0.99 | -$0.79 | -25.32% |
| 2019-12-31 | 2020-03-10 | $N/A | -$0.80 | -$0.78 | -2.56% |
| 2019-09-30 | 2019-11-05 | $N/A | -$0.93 | -$0.85 | -9.41% |
| 2019-06-30 | 2019-08-08 | $30 million | $0.28 | -$0.65 | 143.08% |
| 2019-03-31 | 2019-05-07 | $5.16 million | -$0.57 | -$0.62 | 8.06% |
| 2018-12-31 | 2019-03-19 | $26.14 million | $0.37 | -$0.31 | 219.35% |
| 2018-09-30 | 2018-11-06 | $18.56 million | $0.00 | -$0.65 | 100% |
Principia Biopharma Inc (PRNB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Principia Biopharma Inc (PRNB) Chart:
Principia Biopharma Inc (PRNB) News:
Below you will find a list of latest news for Principia Biopharma Inc (PRNB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Principia Biopharma Inc (PRNB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Principia Biopharma Inc (PRNB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120040793/0001209191-20-040793-index.htm |
| 2019-10-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1510487/000000000019014411/0000000000-19-014411-index.htm |
| 2019-04-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000031506619001494/0000315066-19-001494-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000031506620001177/0000315066-20-001177-index.htm |
| 2020-09-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000031506620001730/0000315066-20-001730-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000083423720007989/0000834237-20-007989-index.htm |
| 2019-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000089924319021804/0000899243-19-021804-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000090221920000237/0000902219-20-000237-index.htm |
| 2018-09-26 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1510487/000090342318000520/0000903423-18-000520-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000090342319000029/0000903423-19-000029-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000090342319000249/0000903423-19-000249-index.htm |
| 2019-10-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092189519002624/0000921895-19-002624-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092189520000547/0000921895-20-000547-index.htm |
| 2020-08-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092189520002285/0000921895-20-002285-index.htm |
| 2020-08-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000092189520002299/0000921895-20-002299-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000092189520002301/0000921895-20-002301-index.htm |
| 2020-08-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1510487/000092189520002317/0000921895-20-002317-index.htm |
| 2018-09-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092963818000763/0000929638-18-000763-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092963819000271/0000929638-19-000271-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000092963820000322/0000929638-20-000322-index.htm |
| 2018-09-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000094787118000778/0000947871-18-000778-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000094787119000395/0000947871-19-000395-index.htm |
| 2019-12-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000094787119000967/0000947871-19-000967-index.htm |
| 2018-09-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465918059133/0001104659-18-059133-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465919008750/0001104659-19-008750-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465920015192/0001104659-20-015192-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465920019983/0001104659-20-019983-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465920021754/0001104659-20-021754-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000110465920021826/0001104659-20-021826-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000114420419006335/0001144204-19-006335-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000114420419007228/0001144204-19-007228-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000114420419007379/0001144204-19-007379-index.htm |
| 2018-10-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312518302123/0001193125-18-302123-index.htm |
| 2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312518310774/0001193125-18-310774-index.htm |
| 2018-11-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312518338506/0001193125-18-338506-index.htm |
| 2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312518353351/0001193125-18-353351-index.htm |
| 2019-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519027103/0001193125-19-027103-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000119312519038098/0001193125-19-038098-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519044374/0001193125-19-044374-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519057225/0001193125-19-057225-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519062224/0001193125-19-062224-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519073126/0001193125-19-073126-index.htm |
| 2019-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519086692/0001193125-19-086692-index.htm |
| 2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519113364/0001193125-19-113364-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312519122384/0001193125-19-122384-index.htm |
| 2019-05-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1510487/000119312519139729/0001193125-19-139729-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519146674/0001193125-19-146674-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519147348/0001193125-19-147348-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519173658/0001193125-19-173658-index.htm |
| 2019-10-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1510487/000119312519259931/0001193125-19-259931-index.htm |
| 2019-10-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1510487/000119312519265060/0001193125-19-265060-index.htm |
| 2019-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519265503/0001193125-19-265503-index.htm |
| 2019-10-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1510487/000119312519265617/0001193125-19-265617-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519267205/0001193125-19-267205-index.htm |
| 2019-10-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1510487/000119312519267711/0001193125-19-267711-index.htm |
| 2019-10-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1510487/000119312519268672/0001193125-19-268672-index.htm |
| 2019-10-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519270067/0001193125-19-270067-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312519308602/0001193125-19-308602-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1510487/000119312520033448/0001193125-20-033448-index.htm |
| 2020-03-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1510487/000119312520068951/0001193125-20-068951-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520119092/0001193125-20-119092-index.htm |
| 2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1510487/000119312520119111/0001193125-20-119111-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312520167090/0001193125-20-167090-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312520221651/0001193125-20-221651-index.htm |
| 2020-08-17 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/1510487/000119312520221652/0001193125-20-221652-index.htm |
| 2020-08-18 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1510487/000119312520222574/0001193125-20-222574-index.htm |
| 2020-08-21 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/1510487/000119312520225813/0001193125-20-225813-index.htm |
| 2020-08-28 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1510487/000119312520233611/0001193125-20-233611-index.htm |
| 2020-08-28 | SC 14D9 | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520233615/0001193125-20-233615-index.htm |
| 2020-09-14 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520245183/0001193125-20-245183-index.htm |
| 2020-09-14 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1510487/000119312520245221/0001193125-20-245221-index.htm |
| 2020-09-17 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520248039/0001193125-20-248039-index.htm |
| 2020-09-22 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1510487/000119312520250596/0001193125-20-250596-index.htm |
| 2020-09-22 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520250608/0001193125-20-250608-index.htm |
| 2020-09-28 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255128/0001193125-20-255128-index.htm |
| 2020-09-28 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255134/0001193125-20-255134-index.htm |
| 2020-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255598/0001193125-20-255598-index.htm |
| 2020-09-28 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255644/0001193125-20-255644-index.htm |
| 2020-09-28 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255650/0001193125-20-255650-index.htm |
| 2020-09-28 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255653/0001193125-20-255653-index.htm |
| 2020-09-28 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1510487/000119312520255655/0001193125-20-255655-index.htm |
| 2020-10-08 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1510487/000119312520265885/0001193125-20-265885-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119003362/0001209191-19-003362-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119003363/0001209191-19-003363-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119003364/0001209191-19-003364-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119003365/0001209191-19-003365-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119003366/0001209191-19-003366-index.htm |
| 2019-02-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119012198/0001209191-19-012198-index.htm |
| 2019-02-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119012231/0001209191-19-012231-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119012249/0001209191-19-012249-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018215/0001209191-19-018215-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018221/0001209191-19-018221-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018223/0001209191-19-018223-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018225/0001209191-19-018225-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018226/0001209191-19-018226-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119018227/0001209191-19-018227-index.htm |
| 2019-04-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119025237/0001209191-19-025237-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119025238/0001209191-19-025238-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036231/0001209191-19-036231-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036235/0001209191-19-036235-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036236/0001209191-19-036236-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036237/0001209191-19-036237-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036239/0001209191-19-036239-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119036246/0001209191-19-036246-index.htm |
| 2019-08-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119047835/0001209191-19-047835-index.htm |
| 2019-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119047836/0001209191-19-047836-index.htm |
| 2019-09-04 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119048210/0001209191-19-048210-index.htm |
| 2019-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119053770/0001209191-19-053770-index.htm |
| 2019-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119053771/0001209191-19-053771-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119054503/0001209191-19-054503-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119057879/0001209191-19-057879-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119060531/0001209191-19-060531-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061189/0001209191-19-061189-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061667/0001209191-19-061667-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120008997/0001209191-20-008997-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120009736/0001209191-20-009736-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120009769/0001209191-20-009769-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016684/0001209191-20-016684-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016688/0001209191-20-016688-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016690/0001209191-20-016690-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016691/0001209191-20-016691-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016693/0001209191-20-016693-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016696/0001209191-20-016696-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120019667/0001209191-20-019667-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120020043/0001209191-20-020043-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120027348/0001209191-20-027348-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120028113/0001209191-20-028113-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120031531/0001209191-20-031531-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035137/0001209191-20-035137-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035140/0001209191-20-035140-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035141/0001209191-20-035141-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035142/0001209191-20-035142-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035143/0001209191-20-035143-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120035144/0001209191-20-035144-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120036824/0001209191-20-036824-index.htm |
| 2020-06-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037483/0001209191-20-037483-index.htm |
| 2020-06-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037484/0001209191-20-037484-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037486/0001209191-20-037486-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120039026/0001209191-20-039026-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120040793/0001209191-20-040793-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120043008/0001209191-20-043008-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047832/0001209191-20-047832-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047842/0001209191-20-047842-index.htm |
| 2020-09-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120051590/0001209191-20-051590-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052222/0001209191-20-052222-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052223/0001209191-20-052223-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052224/0001209191-20-052224-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052225/0001209191-20-052225-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052226/0001209191-20-052226-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052227/0001209191-20-052227-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052228/0001209191-20-052228-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052229/0001209191-20-052229-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052231/0001209191-20-052231-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052233/0001209191-20-052233-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052235/0001209191-20-052235-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000120919120052237/0001209191-20-052237-index.htm |
| 2020-09-28 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1510487/000135445720000530/0001354457-20-000530-index.htm |
| 2019-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1510487/000138713119007820/0001387131-19-007820-index.htm |
| 2020-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1510487/000138713120001835/0001387131-20-001835-index.htm |
| 2020-10-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1510487/000138713120008670/0001387131-20-008670-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459018027401/0001564590-18-027401-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459018027481/0001564590-18-027481-index.htm |
| 2019-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459019008438/0001564590-19-008438-index.htm |
| 2019-03-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1510487/000156459019008448/0001564590-19-008448-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459019016492/0001564590-19-016492-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459019016571/0001564590-19-016571-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459019030782/0001564590-19-030782-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459019030826/0001564590-19-030826-index.htm |
| 2019-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459019033785/0001564590-19-033785-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459019040377/0001564590-19-040377-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459019040415/0001564590-19-040415-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020000767/0001564590-20-000767-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020003759/0001564590-20-003759-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020009739/0001564590-20-009739-index.htm |
| 2020-03-10 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1510487/000156459020009756/0001564590-20-009756-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020018489/0001564590-20-018489-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020021940/0001564590-20-021940-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459020021981/0001564590-20-021981-index.htm |
| 2020-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020028766/0001564590-20-028766-index.htm |
| 2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020030809/0001564590-20-030809-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1510487/000156459020037763/0001564590-20-037763-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1510487/000156459020037804/0001564590-20-037804-index.htm |
| 2019-10-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1510487/999999999519002302/9999999995-19-002302-index.htm |
| 2020-09-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1510487/999999999520002598/9999999995-20-002598-index.htm |
Principia Biopharma Inc (PRNB) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Principia Biopharma Inc (PRNB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 139%Institutional Ownership: 10078%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-01 | Alan Colowick | Director | Sell | 840.00 | 60.07 | 50,456.70 | 0.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120027348/0001209191-20-027348-index.htm |
| 2020-05-05 | Alan Colowick | Director | Sell | 6,660.00 | 60.00 | 399,600.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120027348/0001209191-20-027348-index.htm |
| 2020-07-01 | Alan Colowick | Director | Sell | 7,500.00 | 60.00 | 450,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120040793/0001209191-20-040793-index.htm |
| 2020-05-19 | CHRISTOPHER Y CHAI | Chief Financial Officer | Buy | 5,675.00 | 3.00 | 17,011.95 | 11,039.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120031531/0001209191-20-031531-index.htm |
| 2020-08-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Buy | 7,500.00 | 3.00 | 22,482.75 | 11,039.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047832/0001209191-20-047832-index.htm |
| 2020-03-13 | Roy C. Hardiman | Chief Business Officer | Sell | 100.00 | 51.04 | 5,104.00 | 116,903.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120019667/0001209191-20-019667-index.htm |
| 2020-03-13 | Roy C. Hardiman | Chief Business Officer | Sell | 1,181.00 | 49.46 | 58,407.65 | 117,003.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120019667/0001209191-20-019667-index.htm |
| 2020-06-12 | Roy C. Hardiman | Chief Business Officer | Sell | 863.00 | 62.13 | 53,617.24 | 117,761.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120036824/0001209191-20-036824-index.htm |
| 2020-09-18 | Roy C. Hardiman | Chief Business Officer | Sell | 5,000.00 | 99.98 | 499,917.50 | 117,761.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120051590/0001209191-20-051590-index.htm |
| 2020-03-13 | Roy C. Hardiman | Chief Business Officer | Sell | 3,719.00 | 48.21 | 179,304.15 | 118,184.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120019667/0001209191-20-019667-index.htm |
| 2020-06-12 | Roy C. Hardiman | Chief Business Officer | Sell | 2,542.00 | 61.62 | 156,630.16 | 118,624.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120036824/0001209191-20-036824-index.htm |
| 2019-12-13 | Roy C. Hardiman | Chief Business Officer | Sell | 1,619.00 | 49.83 | 80,681.89 | 120,143.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119060531/0001209191-19-060531-index.htm |
| 2020-09-18 | Roy C. Hardiman | Chief Business Officer | Buy | 2,758.00 | 4.72 | 13,027.69 | 120,519.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120051590/0001209191-20-051590-index.htm |
| 2019-12-13 | Roy C. Hardiman | Chief Business Officer | Buy | 871.00 | 4.72 | 4,114.26 | 121,014.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119060531/0001209191-19-060531-index.htm |
| 2020-06-12 | Roy C. Hardiman | Chief Business Officer | Sell | 1,595.00 | 59.90 | 95,540.98 | 121,166.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120036824/0001209191-20-036824-index.htm |
| 2019-12-13 | Roy C. Hardiman | Chief Business Officer | Sell | 3,381.00 | 49.20 | 166,351.96 | 121,762.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119060531/0001209191-19-060531-index.htm |
| 2020-03-13 | Roy C. Hardiman | Chief Business Officer | Buy | 5,000.00 | 4.72 | 23,618.00 | 121,903.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120019667/0001209191-20-019667-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Buy | 2,500.00 | 3.00 | 7,494.25 | 12,266.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2020-06-12 | Roy C. Hardiman | Chief Business Officer | Buy | 5,000.00 | 4.72 | 23,618.00 | 122,761.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120036824/0001209191-20-036824-index.htm |
| 2020-09-18 | Roy C. Hardiman | Chief Business Officer | Buy | 2,242.00 | 7.27 | 16,292.84 | 122,761.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120051590/0001209191-20-051590-index.htm |
| 2019-12-13 | Roy C. Hardiman | Chief Business Officer | Buy | 4,129.00 | 5.00 | 20,628.90 | 125,143.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119060531/0001209191-19-060531-index.htm |
| 2020-06-23 | Martin Babler | President, CEO | Sell | 515.00 | 60.32 | 31,066.09 | 15,295.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120039026/0001209191-20-039026-index.htm |
| 2019-12-18 | Martin Babler | President, CEO | Sell | 1,295.00 | 54.28 | 70,292.47 | 15,696.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2020-06-23 | Martin Babler | President, CEO | Buy | 15,000.00 | 3.00 | 44,965.50 | 15,810.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120039026/0001209191-20-039026-index.htm |
| 2019-05-21 | ORBIMED ADVISORS LLC | 10% Share Holder | Sell | 1,000,000.00 | 30.25 | 30,250,000.00 | 1,605,713.00 | https://www.sec.gov/Archives/edgar/data/1510487/000094787119000395/0000947871-19-000395-index.htm |
| 2020-07-15 | Dolca Thomas | Chief Medical Officer | Buy | 15,000.00 | 23.77 | 356,550.00 | 16,826.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120043008/0001209191-20-043008-index.htm |
| 2020-08-18 | Dolca Thomas | Chief Medical Officer | Buy | 15,000.00 | 23.77 | 356,550.00 | 16,826.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047842/0001209191-20-047842-index.htm |
| 2019-12-18 | Martin Babler | President, CEO | Sell | 2,205.00 | 53.69 | 118,392.18 | 16,991.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2020-07-15 | Dolca Thomas | Chief Medical Officer | Sell | 15,000.00 | 80.07 | 1,201,069.50 | 1,826.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120043008/0001209191-20-043008-index.htm |
| 2020-08-18 | Dolca Thomas | Chief Medical Officer | Sell | 15,000.00 | 100.00 | 1,500,000.00 | 1,826.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047842/0001209191-20-047842-index.htm |
| 2020-06-15 | Stefani Wolff | Chief Development Officer | Sell | 100.00 | 61.37 | 6,136.80 | 19,096.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037486/0001209191-20-037486-index.htm |
| 2019-12-18 | Martin Babler | President, CEO | Sell | 1,000.00 | 52.77 | 52,774.70 | 19,196.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2020-06-15 | Stefani Wolff | Chief Development Officer | Sell | 5,004.00 | 60.81 | 304,290.74 | 19,196.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037486/0001209191-20-037486-index.htm |
| 2019-08-13 | New Leaf Ventures II, L.P. | 10% Share Holder | Sell | 250,009.00 | 35.00 | 8,750,315.00 | 1,938,167.00 | https://www.sec.gov/Archives/edgar/data/1510487/000089924319021804/0000899243-19-021804-index.htm |
| 2020-06-15 | Stefani Wolff | Chief Development Officer | Sell | 400.00 | 59.89 | 23,957.00 | 24,200.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120037486/0001209191-20-037486-index.htm |
| 2019-11-07 | David Goldstein | Chief Scientific Officer | Sell | 10,000.00 | 32.39 | 323,914.00 | 29,819.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2019-10-18 | PLC GLAXOSMITHKLINE | Insider | Buy | 357,142.00 | 28.00 | 9,999,976.00 | 2,982,855.00 | https://www.sec.gov/Archives/edgar/data/1510487/000138713119007820/0001387131-19-007820-index.htm |
| 2019-10-18 | Simeon George | Director | Buy | 357,142.00 | 28.00 | 9,999,976.00 | 2,982,855.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119053771/0001209191-19-053771-index.htm |
| 2019-11-07 | David Goldstein | Chief Scientific Officer | Buy | 1,127.00 | 0.64 | 716.66 | 30,946.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2020-02-10 | David Goldstein | Chief Scientific Officer | Sell | 5,200.00 | 71.11 | 369,778.76 | 30,968.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120008997/0001209191-20-008997-index.htm |
| 2020-05-07 | David M Goldstein | Chief Scientific Officer | Sell | 2,719.00 | 60.39 | 164,207.21 | 30,968.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120028113/0001209191-20-028113-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 100.00 | 93.34 | 9,334.00 | 31,739.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 1,108.00 | 90.99 | 100,815.92 | 31,839.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 700.00 | 89.68 | 62,772.99 | 32,947.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-06-23 | Martin Babler | President, CEO | Sell | 11,983.00 | 61.82 | 740,744.72 | 3,312.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120039026/0001209191-20-039026-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 2,534.00 | 88.40 | 224,012.19 | 33,647.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-05-07 | David M Goldstein | Chief Scientific Officer | Sell | 3,281.00 | 59.96 | 196,734.01 | 33,687.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120028113/0001209191-20-028113-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Buy | 2,447.00 | 3.00 | 7,335.37 | 34,186.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-05-19 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 7,500.00 | 65.10 | 488,268.00 | 3,539.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120031531/0001209191-20-031531-index.htm |
| 2020-08-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 7,500.00 | 99.37 | 745,239.75 | 3,539.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120047832/0001209191-20-047832-index.htm |
| 2019-12-16 | Stefani Wolff | Chief Development Officer | Sell | 1,300.00 | 49.87 | 64,825.02 | 35,609.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061189/0001209191-19-061189-index.htm |
| 2020-03-16 | Stefani Wolff | Chief Development Officer | Sell | 3,750.00 | 46.36 | 173,838.38 | 35,609.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120020043/0001209191-20-020043-index.htm |
| 2020-02-10 | David Goldstein | Chief Scientific Officer | Sell | 800.00 | 69.53 | 55,621.52 | 36,168.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120008997/0001209191-20-008997-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 700.00 | 86.92 | 60,844.00 | 36,181.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Sell | 858.00 | 86.11 | 73,886.07 | 36,881.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2019-12-16 | Stefani Wolff | Chief Development Officer | Sell | 4,205.00 | 49.29 | 207,265.71 | 36,909.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061189/0001209191-19-061189-index.htm |
| 2020-02-10 | David Goldstein | Chief Scientific Officer | Buy | 6,000.00 | 3.00 | 17,986.20 | 36,968.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120008997/0001209191-20-008997-index.htm |
| 2020-05-07 | David M Goldstein | Chief Scientific Officer | Buy | 6,000.00 | 3.00 | 17,986.20 | 36,968.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120028113/0001209191-20-028113-index.htm |
| 2019-11-07 | David Goldstein | Chief Scientific Officer | Buy | 6,147.00 | 1.91 | 11,726.02 | 37,093.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2020-08-10 | David M Goldstein | Chief Scientific Officer | Buy | 3,553.00 | 3.18 | 11,296.41 | 37,739.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120046484/0001209191-20-046484-index.htm |
| 2019-11-07 | David Goldstein | Chief Scientific Officer | Buy | 1,651.00 | 1.91 | 3,149.45 | 38,744.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2019-08-13 | New Leaf Ventures II, L.P. | 10% Share Holder | Sell | 49,991.00 | 35.00 | 1,749,685.00 | 387,546.00 | https://www.sec.gov/Archives/edgar/data/1510487/000089924319021804/0000899243-19-021804-index.htm |
| 2020-03-03 | Martin Babler | President, CEO | Sell | 300.00 | 64.83 | 19,448.01 | 39,179.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016684/0001209191-20-016684-index.htm |
| 2020-03-16 | Stefani Wolff | Chief Development Officer | Sell | 1,754.00 | 45.72 | 80,192.18 | 39,359.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120020043/0001209191-20-020043-index.htm |
| 2020-03-03 | Martin Babler | President, CEO | Sell | 5,432.00 | 64.10 | 348,180.34 | 39,479.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016684/0001209191-20-016684-index.htm |
| 2019-11-07 | David Goldstein | Chief Scientific Officer | Buy | 1,075.00 | 3.00 | 3,222.53 | 39,819.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119055897/0001209191-19-055897-index.htm |
| 2020-03-16 | Stefani Wolff | Chief Development Officer | Buy | 5,504.00 | 4.54 | 24,999.17 | 41,113.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120020043/0001209191-20-020043-index.htm |
| 2019-12-16 | Stefani Wolff | Chief Development Officer | Buy | 5,505.00 | 4.54 | 25,003.71 | 41,114.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061189/0001209191-19-061189-index.htm |
| 2020-03-03 | Martin Babler | President, CEO | Sell | 7,183.00 | 63.24 | 454,251.48 | 44,911.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016684/0001209191-20-016684-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 76.00 | 68.52 | 5,207.66 | 4,766.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 2,240.00 | 68.13 | 152,611.65 | 4,842.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2019-12-19 | Dolca Thomas | Chief Medical Officer | Sell | 495.00 | 60.00 | 29,700.00 | 494.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061667/0001209191-19-061667-index.htm |
| 2020-03-03 | Martin Babler | President, CEO | Sell | 2,085.00 | 62.45 | 130,203.25 | 52,094.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120016684/0001209191-20-016684-index.htm |
| 2019-10-18 | Daniel J. Becker | Director | Buy | 535,000.00 | 28.00 | 14,980,000.00 | 535,000.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119053770/0001209191-19-053770-index.htm |
| 2019-12-17 | Martin Babler | President, CEO | Sell | 1,014.00 | 54.36 | 55,115.97 | 54,179.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2019-12-17 | Martin Babler | President, CEO | Sell | 6,661.00 | 53.94 | 359,313.66 | 55,193.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2019-10-28 | Daniel J. Becker | Director | Buy | 68,404.00 | 33.41 | 2,285,548.65 | 603,404.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119054503/0001209191-19-054503-index.htm |
| 2019-10-29 | Daniel J. Becker | Director | Buy | 9,196.00 | 33.98 | 312,477.32 | 612,600.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119054503/0001209191-19-054503-index.htm |
| 2019-12-17 | Martin Babler | President, CEO | Sell | 11,485.00 | 52.86 | 607,063.79 | 61,854.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2020-05-05 | Alan Colowick | Director | Buy | 6,660.00 | 4.54 | 30,249.72 | 6,660.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120027348/0001209191-20-027348-index.htm |
| 2019-11-20 | Daniel J. Becker | Director | Buy | 55,000.00 | 29.94 | 1,646,700.00 | 667,600.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119057879/0001209191-19-057879-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 605.00 | 67.08 | 40,582.19 | 7,082.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2019-12-17 | Martin Babler | President, CEO | Sell | 5,840.00 | 51.80 | 302,502.07 | 73,339.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919119061423/0001209191-19-061423-index.htm |
| 2020-07-01 | Alan Colowick | Director | Buy | 7,500.00 | 4.54 | 34,065.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120040793/0001209191-20-040793-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 1,350.00 | 65.94 | 89,021.03 | 7,687.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2020-06-23 | Martin Babler | President, CEO | Sell | 2,502.00 | 62.38 | 156,077.76 | 810.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120039026/0001209191-20-039026-index.htm |
| 2020-05-01 | Alan Colowick | Director | Buy | 840.00 | 4.54 | 3,815.28 | 840.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120027348/0001209191-20-027348-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 545.00 | 64.91 | 35,374.59 | 9,037.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |
| 2020-02-18 | CHRISTOPHER Y CHAI | Chief Financial Officer | Sell | 2,684.00 | 63.86 | 171,388.97 | 9,582.00 | https://www.sec.gov/Archives/edgar/data/1510487/000120919120011163/0001209191-20-011163-index.htm |